Press Release

UAW Retiree Medical Benefits Trust Joins Campaign for Sustainable Rx Pricing

Read More
ICYMI: May 21, 2015

New poll shows 75% of Americans find Rx prices are just too high.

Read More
A Look at the Risk to Patients and the Health Care System

New! Specialty Drug Hyperinflation White Paper

Read the White Paper

Are Skyrocketing Drug Prices Really Needed for Innovation?

Read More

We need a better way.

Read more
Want to learn more? Let us know how to reach you for updates.

  • Threaten access to care
  • Raise out of pocket costs
  • Create higher premiums
  • Raise taxes
  • Threaten care infrastructure
Need More info?
Please reach out to us with any questions.

Contact Us

  • "There are no multiple sclerosis drugs available in the United States with a list price below $50,000 a year"

  • U.S. spending on prescription drugs saw the largest increase since 2001, with the nation’s pharmacy bill rising to $373.9 billion last year as new treatments came to market and manufacturers increased prices on old ones.

  • circle-person-60px

    For the price of Sovaldi for one patient, we could provide health insurance through Medicaid for [up to] 26 people for an entire year.

  • circle-person-60px

    [Solvadi's price] has the potential to throw a wrench into short-term state budgets.

Learn more about how you can help bring reasonable drug prices to this country.

Contact Us